Cit Group Inc (CIT) 32.16 $CIT CIT Bank Provides

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cit Group Inc [Del] (CIT) 32.16 $CIT

CIT Bank Provides $100,000 Grant to COR Community Development Corporation
BusinessWire - Mon Jun 13, 7:30AM CDT
--Participants Will Go Through a Rigorous Financial Education Program and Create a Business Plan
CIT: 32.16 (-0.56)

New Strong Sell Stocks for June 9th
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:03AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
EXPR: 14.28 (-0.15), HLI: 24.17 (+0.25), WMS: 25.84 (-0.51), GTN: 11.05 (-0.21), CIT: 32.16 (-0.56)

Employment Growth Supports Commercial Real Estate Amid Regulatory Uncertainty
BusinessWire - Wed Jun 08, 7:30AM CDT
--Commercial Real Estate Market Prepares for New Regulations
CIT: 32.16 (-0.56)

CIT Group Ratings Upgraded by Moody's, Outlook Stable
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 7:14AM CDT
Moody's upgraded the senior unsecured rating of CIT Group (CIT) from B1 to Ba3.
EEFT: 77.73 (-0.83), CIT: 32.16 (-0.56), AMTG: 13.50 (-0.10), MCO: 98.32 (-1.12)

Watch for CIT Group to Potentially Rebound After Falling 1.46% Yesterday
Comtex SmarTrend(R) - Wed Jun 01, 3:08PM CDT
CIT Group (NYSE:CIT) traded in a range yesterday that spanned from a low of $32.87 to a high of $33.99. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $33.44 on volume of 953,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CIT: 32.16 (-0.56)

CIT Group Aircraft Leasing Unit Draws Bids from China, Japan
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:34AM CDT
CIT Group (CIT) is said to be considering spin-off or sale of its aircraft leasing unit by the end of this year in order to simplify operations and focus more on domestic banking.
EEFT: 77.73 (-0.83), CIT: 32.16 (-0.56), AMTG: 13.50 (-0.10)

New Strong Sell Stocks for May 31st
Swarup Gupta - Zacks Investment Research - Tue May 31, 8:27AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
ABAX: 45.54 (+0.01), ASB: 17.83 (-0.22), AHT: 5.19 (-0.03), CIT: 32.16 (-0.56), MATX: 33.31 (+0.03)

CIT Provides $35 Million Financing for the Bascom Group and Oaktree
BusinessWire - Thu May 26, 7:30AM CDT
CIT Group Inc. (NYSE:CIT), cit.com, a leading provider of commercial lending and leasing services, today announced that CIT Real Estate Finance provided a $35 million senior secured mortgage loan to a special purpose entity controlled by The Bascom Group ("Bascom", an owner/operator of multifamily properties, and funds managed by Oaktree Capital Management, L.P. ("Oaktree", a global investment manager specializing in alternative investments. The proceeds of the facility were used to finance the acquisition of Stone Creek Apartments, a 368-unit apartment complex located in Sacramento, California. Financing was provided by CIT Bank, N.A., the principal bank subsidiary of CIT. Terms of the transaction were not disclosed.
CIT: 32.16 (-0.56)

New Strong Sell Stocks for May 23rd
Swarup Gupta - Zacks Investment Research - Mon May 23, 8:29AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday.
AAP: 152.55 (-0.47), ASB: 17.83 (-0.22), CIT: 32.16 (-0.56), BRCD: 8.84 (-0.03), BKE: 25.08 (-0.01)

CIT Serves as Joint Lead Arranger in $65 Million Financing of Blue Wolf Capital Partners' Acquisition of National Home Health Care
BusinessWire - Thu May 19, 7:30AM CDT
--National Home Health Care Is a Home Health Provider That Offers a Range of Personal Care and Skilled Nursing Services
CIT: 32.16 (-0.56)

Private Equity Finds Opportunities in Healthcare as Affordable Care Act Drives Fee for Value Model
BusinessWire - Wed May 18, 7:30AM CDT
--Fee for Value Gains Traction as Affordable Care Act Implementation Continues
CIT: 32.16 (-0.56)

Capital Markets Present Opportunities; Participants Adapting to Lending Guidelines
BusinessWire - Thu May 12, 7:30AM CDT
--Capital Markets are in Uncertain Period; Liquidity is Mixed with Hesitancy
CIT: 32.16 (-0.56)

Commercial Real Estate Executives Show Mixed Optimism for 2016
BusinessWire - Mon May 09, 7:30AM CDT
--52% of Respondents Say Their Market Segment Is Strong or Very Strong
CIT: 32.16 (-0.56)

New Strong Sell Stocks for May 5th
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:14AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
BDGE: 29.34 (-0.18), CAI: 7.48 (-0.37), CAR: 32.00 (-0.86), ABIL: 3.55 (+0.16), CIT: 32.16 (-0.56)

CIT Appoints Denise M. Menelly Executive Vice President and Head of Technology and Operations
BusinessWire - Tue May 03, 7:30AM CDT
CIT Group Inc. (NYSE:CIT), cit.com, a leading provider of commercial lending and leasing services, today announced the appointment of Denise M. Menelly (54) as Executive Vice President and Head of Technology and Operations, effective June 29. Raymond Matsumoto, Executive Vice President and Chief Administrative Officer, will serve as the Head of Technology and Operations in the interim. Menelly will serve on the company's Executive Management Committee and report directly to Chief Executive Officer Ellen Alemany.
CIT: 32.16 (-0.56)

CIT Capital Equipment Finance Continues to Grow with Appointment of Industry Leaders
BusinessWire - Mon May 02, 7:30AM CDT
CIT Group Inc. (NYSE:CIT), cit.com, a leading provider of commercial lending and leasing services, today announced that CIT Capital Equipment Finance made several additional appointments designed to further build a best-in-class team focused on creating tailored capital equipment financing solutions for middle market companies.
CIT: 32.16 (-0.56)

CIT Group (CIT) Q1 Earnings Lag on High Costs & Provisions
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 10:10AM CDT
CIT Group (CIT) reported first-quarter 2016 earnings from continuing operations of 75 cents per share, which fell short of the Zacks Consensus Estimate of 77 cents.
BANX: 17.84 (-0.12), ONDK: 4.93 (-0.18), CIT: 32.16 (-0.56), GFN: 4.15 (+0.01)

CIT misses 1Q profit forecasts
Automated Insights - Thu Apr 28, 7:31AM CDT
NEW YORK (AP) _ CIT Group Inc. (CIT) on Thursday reported first-quarter profit of $146.9 million.
CIT: 32.16 (-0.56)

CIT Reports First Quarter 2016 Net Income of $147 Million ($0.73 Per Diluted Share); Income from Continuing Operations of $152 Million ($0.75 Per Diluted Share)
BusinessWire - Thu Apr 28, 5:30AM CDT
--Grew Commercial Portfolio - Financing and leasing assets in Commercial Banking were up 2% from the prior quarter;
CIT: 32.16 (-0.56)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading